SCHEMBL655655

SCHEMBL655655

Cc1cc([N+](=O)[O-])cc(C)c1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 5/20 0.77
ALDH1A1 P00352 4/20 0.77
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
HTT P42858 2/20 0.61
LMNA P02545 1/20 0.61
TSHR P16473 3/20 0.56
TDP1 Q9NUW8 3/20 0.56
GALR3 O60755 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CYP3A4 P08684 2/20 0.52
HSD17B10 Q99714 2/20 0.52
KDM4E B2RXH2 1/20 0.52
TTR P02766 1/20 0.52
CYP1A2 P05177 1/20 0.52
MAPT P10636 1/20 0.52
CYP2C9 P11712 1/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69972 0.89 GPR35 (0.69) GPR35ALDH1A1MEN1KMT2AHTT
SCHEMBL12933087 0.87 MEN1 (0.84) GPR35ALDH1A1MEN1KMT2AHTT
Dinitro Cresol SCHEMBL8873755 0.87 GPR35 (1.00) GPR35ALDH1A1MEN1KMT2AHTT
SCHEMBL28009106 0.87 GPR35 (0.67) GPR35ALDH1A1MEN1KMT2AHTT
Dinitro Cresol SCHEMBL20734 0.87 GPR35 (1.00) GPR35ALDH1A1MEN1KMT2AHTT
Dinitro Cresol SCHEMBL29430312 0.87 GPR35 (1.00) GPR35ALDH1A1MEN1KMT2AHTT
SCHEMBL25276334 0.86 ALDH1A1 (0.65) GPR35ALDH1A1MEN1KMT2AHTT
Dinitro Cresol SCHEMBL1260257 0.86 GPR35 (0.96) GPR35ALDH1A1MEN1KMT2AHTT
SCHEMBL8505242 0.86 ALDH1A1 (0.65) GPR35ALDH1A1MEN1KMT2AHTT
Dinitro Cresol SCHEMBL711035 0.86 GPR35 (0.96) GPR35ALDH1A1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114235541-B Method for rapidly determining 12 nitrophenol compounds in industrial wastewater 甘肃中商食品质量检验检测有限公司 2023-09-22 CN claimed
CN-112630322-B Method for detecting phenolic compounds in fish 宁波市产品食品质量检验研究院(宁波市纤维检验所) 2022-09-16 CN claimed
CN-112611824-B Method for detecting phenolic compounds in carapace 宁波市产品食品质量检验研究院(宁波市纤维检验所) 2022-09-16 CN claimed
CN-111474266-B Method for detecting phenolic compounds in water 宁波市产品食品质量检验研究院(宁波市纤维检验所) 2022-08-02 CN claimed
CN-112630322-A Method for detecting phenolic compounds in fish 宁波市产品食品质量检验研究院(宁波市纤维检验所) 2021-04-09 CN claimed
CN-112611824-A Method for detecting phenolic compounds in carapace 宁波市产品食品质量检验研究院(宁波市纤维检验所) 2021-04-06 CN claimed
CN-111474266-A Method for detecting phenolic compounds in water 宁波市食品检验检测研究院 2020-07-31 CN claimed
US-20110015108-A1 Aqueous Buffered Fluoride-Containing Etch Residue Removers and Cleaners AIR PRODUCTS AND CHEMICALS, INC. (US) 2011-01-20 US claimed
US-7807613-B2 Aqueous buffered fluoride-containing etch residue removers and cleaners AIR PRODUCTS AND CHEMICALS, INC. (US) 2010-10-05 US claimed
CN-1944537-B Nanocomposite, nanocomposite electrolyte membrane and fuel using the same SAMSUNG SDI CO LTD 2010-05-12 CN claimed
US-20030166746-A1 Organic component comprises long-chain cycloaliphatic epoxy resin, short-chain cycloaliphatic epoxy resin, cyanate ester, lewis acid catalyst; useful in die attach adhesives, underfills, encapsulants, via fills, prepreg binders ZHOU XIAO-QI (US) 2003-09-04 US claimed
US-6489380-B1 MIXTURES OF FILLERS, HETEROCYLIC ETHERS, NITRILES, LEWIS ACID CATALYSTS AND/OR BROWNSTED ACIDS HAVING HIGH FLEXIBILITY AND HERMETIC SEALING, USED IN SEMICONDUCTOR APPLICATIONS JOHNSON MATTHEY ELECTRONICS, INC. 2002-12-03 US claimed
US-20020115668-A1 Trisubstituted 1,3,5-triazine derivatives DAEYAERT FREDERIK FRANS DESIRE (BE) 2002-08-22 US claimed
EP-1066269-A1 TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS JANSSEN PHARMACEUTICA N.V. (BE) 2001-01-10 EP claimed
US-6150360-A ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE JANSSEN PHARMACEUTICA N.V. (BE) 2000-11-21 US claimed
US-6057402-A BLEND OF CYCLOALIPHATIC EPOXY RESINS, CYANATE ESTERS, LEWIS ACID CATALYST AND FLEXIBILITY MODIFIER JOHNSON MATTHEY, INC. (US) 2000-05-02 US claimed
WO-1999050256-A1 TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS JANSSEN PHARMACEUTICA N.V. (BE) 1999-10-07 WO claimed
EP-0304248-B1 CARBON DIOXIDE SENSOR Pfizer Hospital Products Group, Inc. (US) 1992-11-19 EP claimed
US-4851195-A FOR DETERMINING LIQUID PARTIAL PRESSURE; CONTAINING AN ABSORBER, A FLUORESCER AND BICARBONATE PFIZER HOSPITAL PRODUCTS GROUP, INC. (US) 1989-07-25 US claimed
EP-0304248-A2 Carbon dioxide sensor Pfizer Hospital Products Group, Inc. (US) 1989-02-22 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115668-A1 Trisubstituted 1,3,5-triazine derivatives XDH, CCR5, CXCR1 GPR35 1184/4885ALDH1A1 3722/4885MEN1 4382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.